American Academy of Dermatology | www.aad.org
The American Academy of Dermatology was founded in 1938. It is the largest, most influential and representative dermatology group in the United States. With a membership of more than 19,000, it represents virtually all practicing dermatologists in the United States, as well as a growing number of international dermatologists.
American Academy of Family Physicians | www.aafp.org
The American Academy of Family Physicians is the national association of family doctors. It is one of the largest national medical organizations, with 124,900 members in 50 states, DC, Puerto Rico, the Virgin Islands, and Guam, as well as internationally.
American Academy of Pediatrics | www.aap.org
The American Academy of Pediatrics is an organization of 64,000 primary care physicians, pediatric medical subspecialists, and pediatric surgical specialists with a mission to attain optimal physical, mental, and social health and well-being for all infants, children, adolescents, and young adults.
American Academy of Podiatric Sports Medicine | www.aapsm.org
The American Academy of Podiatric Sports Medicine serves to advance the understanding, prevention and management of lower extremity sports and fitness injuries. It believes that providing such knowledge to the profession and the public will optimize enjoyment and safe participation in sports and fitness activities. It will accomplish this mission through professional education, scientific research, public awareness, and membership support.
American College of Obstetricians and Gynecologists | www.acog.org
Founded in 1951, the American College of Obstetricians and Gynecologists (The College) is the specialty's premier professional membership organization dedicated to the improvement of women's health. With more than 58,000 members, the College is a 501(c)(3) organization and its activities include producing the College's practice guidelines and other educational material.
American Podiatric Medical Association | www.apma.org
Founded in 1912, the American Podiatric Medical Association (APMA), headquartered in Bethesda, MD, is the leading resource for foot and ankle health information. Currently, the organization represents a vast majority of the estimated 17,775 podiatrists in the country.
American Sexual Health Association | www.ashastd.org
American Sexual Health Association (ASHA) was founded in 1914 in New York City. Now, more than 100 years after its creation, ASHA remains America's nonprofit authority for sexual health information.
Centers for Disease Control and Prevention | www.cdc.gov
Centers for Disease Control and Prevention (CDC) works 24/7 to protect America from health, safety, and security threats, both foreign and in the US. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same. CDC increases the health security of our nation. As the nation's health protection agency, CDC saves lives and protects people from health threats. To accomplish its mission, CDC conducts critical science and provides health information that protects our nation against expensive and dangerous health threats, and responds when these arise.
Dermatology Nurses' Association | www.dnanurse.org
The Dermatology Nurses' Association (DNA) is a professional nursing organization comprised of a diverse group of individuals committed to quality care through sharing knowledge and expertise. The core purpose of the DNA is to promote excellence in dermatologic care.
Mayo Clinic | www.mayoclinic.org
Mayo Clinic is a nonprofit organization committed to clinical practice, education, and research, providing expert, whole-person care to everyone who needs healing.
National Institutes of Health | www.nih.gov
The National Institutes of Health (NIH), a part of the US Department of Health and Human Services, is the nation's medical research agency—its mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability.
National Psoriasis Foundation | www.psoriasis.org
The National Psoriasis Foundation (NPF) is a non-profit organization with a mission to drive efforts to cure psoriatic disease and improve the lives of those affected. Founded in 1966 from a tiny classified ad in a Portland, OR newspaper, the NPF has evolved to become the leading patient advocacy group for the more than 8 million Americans living with psoriasis and psoriatic arthritis.
Planned Parenthood | www.plannedparenthood.org
In October 2016, Planned Parenthood turned 100 years strong. Planned Parenthood was founded on the revolutionary idea that women should have the information and care they need to live strong, healthy lives and fulfill their dreams—no ceilings, no limits. Today, Planned Parenthood is a trusted health care provider, an informed educator, a passionate advocate, and a global partner helping similar organizations around the world. Planned Parenthood delivers vital reproductive health care, sex education, and information to millions of women, men, and young people worldwide.
Society of Dermatology Physician Assistants | www.dermpa.org
The Society of Dermatology Physician Assistants (SDPA) is a 501(c)(6) non-profit professional organization composed of members who provide dermatologic care or have an interest in the medical specialty of dermatology. Its fellow members are PAs who provide medical services with the collaboration of a board-certified dermatologist. Founded in 1994, the SDPA currently has more than 2,700 members.
The American College of Foot and Ankle Orthopedics and Medicine | www.acfaom.org
The American College of Foot and Ankle Orthopedics and Medicine (ACFAOM) was founded in 1949 and incorporated in 1951 as the American College of Foot Orthopedists (ACFO). The name was changed in the early 1990s to better reflect the scope of interest of the membership. ACFAOM’s purpose is to support scientific study and research to enhance the field of foot orthopedics and related matters in podiatric medicine. With over 1,200 active members, ACFAOM is the second largest APMA-affiliated specialty College.

KERYDIN® Indication and Important Safety Information

Pandel® Cream Indication and Important Safety Information

OXISTAT® Lotion Indication and Important Safety Information

VEREGEN® Indication and Important Safety Information

ApexiCon® E Cream Indication and Important Safety Information

 

KERYDIN® Indication

KERYDIN® is a topical prescription medicine used to treat fungal infections of the toenails.

Important Safety Information

KERYDIN® is for use on toenails only. Do not use KERYDIN® in your mouth, eyes, or vagina.

Tell your doctor about all of your medical conditions, including if you are pregnant or plan to become pregnant or are breastfeeding or plan to breastfeed. It is not known if KERYDIN® can harm your unborn baby or if KERYDIN® passes into your breast milk. It is not known if KERYDIN® is safe and effective in children.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Use KERYDIN® exactly as your healthcare provider tells you to use it. Avoid getting KERYDIN® on skin that is not surrounding the treated toenail. KERYDIN® is flammable. Avoid heat and flame while applying KERYDIN® to your toenail.

KERYDIN® may cause irritation at the treated site. The most common side effects include: skin peeling, ingrown toenail, redness, itching, and swelling. Tell your doctor if you have any side effect that bothers you or does not go away.

Please see link to Full Prescribing Information below.

KERYDIN® (tavaborole) Topical Solution, 5% Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

[back to top]

 

PANDEL® Cream Indication

PANDEL® (hydrocortisone probutate) Cream, 0.1% is a topical prescription medication for the relief of the inflammatory (redness) and pruritic (itching) manifestations of corticosteroid-responsive skin conditions in patients 18 years of age or older.

Important Safety Information

This medication is for topical use only. Avoid contact with the eyes. The treated skin area should not be bandaged or otherwise covered or wrapped, unless directed by the physician. Therapy should be stopped when your condition gets better. If no improvement is seen within two weeks, contact the physician.

PANDEL can pass through your skin and cause adrenal gland problems. This is more likely to happen if you use PANDEL for too long, use it with other medicines that contain corticosteroids, apply it on a large area of your skin or apply it on broken skin, cover the treated area, have liver failure, or use it in pediatric patients. Your healthcare provider may do blood tests to check your adrenal gland function during and after treatment with PANDEL. Various hormonal abnormalities, increased blood sugar, and revealing underlying diabetes mellitus can also result from topical corticosteroids passing through your skin. Pediatric patients may be more susceptible to systemic toxicity.

Allergic contact dermatitis (rash) with corticosteroids is usually identified by a failure to heal rather than worsening of the condition, as seen with most topical products not containing corticosteroids. If irritation develops, discontinue PANDEL and institute appropriate therapy.

If you are pregnant or nursing a baby, consult with your physician prior to using this product.

The most frequent adverse reactions include burning, stinging, rash, red, bumpy rash, redness, itching, moderate tingling or prickling feeling, and allergic rash. Local adverse reactions that have been reported with topical corticosteroids include itching, irritation, dryness, folliculitis (swelling of the hair follicles), hypertrichosis (excessive hair growth), acneiform eruptions (acne or rashes resembling acne), hypopigmentation (loss of skin color), perioral dermatitis (rash around the mouth), allergic contact dermatitis (rash), secondary infections, skin atrophy (thinning), striae (lines on the skin), and miliaria (rash due to blocking of the sweat glands, 'prickly heat').

Please see the link to the Full Prescribing Information below.

Pandel® (hydrocortisone probutate) Cream, 0.1% Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

[back to top]

 

OXISTAT® Lotion Indication

OXISTAT® Lotion is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum.

Important Safety Information

Do not use OXISTAT® Lotion if you have hypersensitivity to any ingredient of this product.

Use the product only externally. OXISTAT® Lotion is not to be used in the eyes or vagina. Avoid contact with the eyes, nose, mouth, and other mucous membranes. Do not cover the treated area unless directed otherwise by your physician.

Use the medication for the full treatment time recommended by your physician, even though symptoms may have improved.

Inform the physician if the area of application shows signs of increased irritation, itching, burning, blistering, swelling, or oozing. In clinical studies with OXISTAT® Lotion, the most commonly reported side effects were burning and stinging; less commonly reported side effects were itching, scaling, tingling, pain, and blistering.

If you are pregnant or nursing a baby, consult with your physician prior to using this product. For more information, consult your physician.

Please see link to the Full Prescribing Information below.

OXISTAT® (oxiconazole nitrate) Lotion, 1% Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

[back to top]

 

VEREGEN® Indication

VEREGEN® is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older.

Important Safety Information

Do not use VEREGEN® Ointment, 15% if you are allergic to any ingredient in this product. Do not use VEREGEN® Ointment, 15% for warts in the vagina, cervix, or inside the anus. Avoid contact with your eyes, nostrils and mouth while ointment is on your finger(s).

Avoid use of VEREGEN® on open wounds. Do not expose skin that has been treated with VEREGEN® to the sunlight, sunlamps or tanning beds. Tell your doctor if you are using any other type of skin product on the area to be treated. Avoid sexual contact (genital, anal or oral) when VEREGEN® Ointment, 15% is on your genital or perianal skin. If you do choose to have sexual contact, you must wash off the ointment carefully before having protected sexual contact as the ointment may weaken condoms and vaginal diaphragms.

Be sure to tell the doctor if you have a weak immune system, if you are pregnant or nursing a baby, or if you have used VEREGEN® before. Avoid using this product in patients younger than 18 years of age or for longer than 16 weeks. If your warts do not go away or come back after treatment contact your doctor.

The most common side effects with VEREGEN® Ointment, 15% are local skin and application site reactions including (incidence ≥ 20%): redness, itching, burning, pain, sores, swelling, hard spots, rash with blisters.

For more information, consult your healthcare professional.

You are encouraged to report negative side effects of prescription drugs to the Food and Drug Administration (FDA). Please visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

If you have a product complaint about VEREGEN®, please call PharmaDerm customer service at 1-800-525-8747.

The information on this website should not take the place of talking with your healthcare professional. If you need medical information, please talk to your healthcare professional.

Please see link to full Patient Information. VEREGEN® (sinecatechins) Ointment, 15% Patient Information

Please see link to full Prescribing Information. VEREGEN® (sinecatechins) Ointment, 15% Full Prescribing Information

[back to top]

 

ApexiCon® E Cream Indication

ApexiCon® E Cream is a topical prescription medication for the relief of the inflammatory (redness) and pruritic (itching) manifestations of corticosteroid-responsive skin conditions (such as atopic dermatitis or psoriasis).

Important Safety Information

Do not use ApexiCon® E Cream if you have a history of hypersensitivity to any of the ingredients of the preparation. If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted. This medication is for external use only. Avoid contact with the eyes. The treated skin area should not be bandaged or otherwise covered or wrapped unless directed by the physician. Do not use tight-fitting diapers or plastic pants on an infant or child being treated in the diaper area, as this may increase the likelihood of the side effects.

Systemic absorption of topical corticosteroids through the skin has produced various hormonal abnormalities, increased blood sugar, and sugar in the urine in some patients. The following local side effects have been reported most commonly with topical corticosteroids: burning, itching, irritation, dryness.

The safety and effectiveness of this product in pediatric patients have not been established. Pediatric patients are more likely to develop toxicity affecting various organs. Side effects of topical steroids in children may include problems with growth, weight gain, headaches, problems with vision, bulging soft spots on a baby's head, and stretch marks.

If you are pregnant or nursing a baby, consult with physician prior to using this product.

For more information, consult your healthcare professional. Please see link to Full Prescribing Information below.

ApexiCon® E Cream (diflorasone diacetate cream USP 0.05% [emollient]) Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

[back to top]